The glycosylation status of PrPC is a key factor in determining transmissible spongiform encephalopathy transmission between species

Journal of Virology

Volumn 89, Issue 9, 2015, Pages 4738-4747

  Wiseman, Frances K ^a,d   Cancellotti, Enrico ^a   Piccardo, Pedro ^a,c   Iremonger, Kayleigh ^a,e   Boyle, Aileen ^a   Brown, Deborah ^a   Ironside, James W ^b   Manson, Jean C ^a   Diack, Abigail B ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN; POLYSACCHARIDE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VACUOLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE RESISTANCE; DISEASE TRANSMISSION; HAMSTER STRAIN; HOST SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INCUBATION TIME; MOUSE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; SURVIVAL TIME; VARIANT CREUTZFELDT JAKOB DISEASE AGENT; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION; ANIMAL; DISEASE PREDISPOSITION; FEMALE; GLYCOSYLATION; HAMSTER; MALE; METABOLISM; TRANSMISSION; VETERINARY;

CRICETINAE; MUS;

ANIMALS; CRICETINAE; DISEASE RESISTANCE; DISEASE SUSCEPTIBILITY; FEMALE; GLYCOSYLATION; HUMANS; MALE; MICE; POLYSACCHARIDES; PRION DISEASES; PRPC PROTEINS;

EID: 84928531956     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02296-14     Document Type: Article

References (60)

1. Prusiner SB. 1998. Prions. Proc Natl Acad Sci USA 95:13363-13383. http://dx.doi.org/10.1073/pnas.95.23.13363.
2. Will RG. 2003. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull 66:255-265. http://dx.doi.org/10.1093/bmb/66.1.255.
3. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C. 1993. Mice devoid of PrP are resistant to scrapie. Cell 73:1339-1347. http://dx.doi.org/10.1016/0092-8674(93)90360-3.
4. Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, Hope J. 1994. 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 8:121-127. http://dx.doi.org/10.1007/BF02780662.
5. Prusiner SB. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216:136-144. http://dx.doi.org/10.1126/science.6801762.
6. Beringue V, Vilotte JL, Laude H. 2008. Prion agent diversity and species barrier. Vet Res 39:47. http://dx.doi.org/10.1051/vetres:2008024.
7. Castilla J, Gonzalez-Romero D, Saa P, Morales R, De Castro J, Soto C. 2008. Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions. Cell 134:757-768. http://dx.doi.org/10.1016/j.cell.2008.07.030.
8. Manson JC, Cancellotti E, Hart P, Bishop MT, Barron RM. 2006. The transmissible spongiform encephalopathies: emerging and declining epidemics. Biochem Soc Trans 34:1155-1158. http://dx.doi.org/10.1042/BST0341155.
9. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett C, Cousens S, Fraser H, Bostock CJ. 1997. Transmissions to mice indicate that "new variant" CJD is caused by the BSE agent. Nature 389:498-501. http://dx.doi.org/10.1038/39057.
10. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG. 1996. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921-925. http://dx.doi.org/10.1016/S0140-6736(96)91412-9.
11. Kirkwood JK, Cunningham AA. 1994. Epidemiological observations on spongiform encephalopathies in captive wild animals in the British Isles. Vet Rec 135:296-303. http://dx.doi.org/10.1136/vr.135.13.296.
12. Vaccari G, Panagiotidis CH, Acin C, Peletto S, Barillet F, Acutis P, Bossers A, Langeveld J, van Keulen L, Sklaviadis T, Badiola JJ, Andreeoletti O, Groschup MH, Agrimi U, Foster J, Goldmann W. 2009. State-of-the-art review of goat TSE in the European Union, with special emphasis on PRNP genetics and epidemiology. Vet Res 40:48. http://dx.doi.org/10.1051/vetres/2009031.
13. Bruce M, Chree A, McConnell I, Foster J, Pearson G, Fraser H. 1994. Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Philos Trans R Soc Lond B Biol Sci 343:405-411. http://dx.doi.org/10.1098/rstb.1994.0036.
14. Heisey DM, Mickelsen NA, Schneider JR, Johnson CJ, Langenberg JA, Bochsler PN, Keane DP, Barr DJ. 2010. Chronic wasting disease (CWD) susceptibility of several North American rodents that are sympatric with cervid CWD epidemics. J Virol 84:210-215. http://dx.doi.org/10.1128/JVI.00560-09.
15. Browning SR, Mason GL, Seward T, Green M, Eliason GA, Mathiason C, Miller MW, Williams ES, Hoover E, Telling GC. 2004. Transmission of prions from mule deer and elk with chronic wasting disease to transgenic mice expressing cervid PrP. J Virol 78:13345-13350. http://dx.doi.org/10.1128/JVI.78.23.13345-13350.2004.
16. Scott M, Foster D, Mirenda C, Serban D, Coufal F, Walchli M, Torchia M, Groth D, Carlson G, DeArmond SJ, Westaway D, Prusiner SB. 1989. Transgenic mice expressing hamster prion protein produce speciesspecific scrapie infectivity and amyloid plaques. Cell 59:847-857. http://dx.doi.org/10.1016/0092-8674(89)90608-9.
17. Cancellotti E, Barron RM, Bishop MT, Hart P, Wiseman F, Manson JC. 2007. The role of host PrP in transmissible spongiform encephalopathies. Biochim Biophys Acta 1772:673-680. http://dx.doi.org/10.1016/j.bbadis.2006.10.013.
18. Barron RM, Thomson V, Jamieson E, Melton DW, Ironside J, Will R, Manson JC. 2001. Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers. EMBO J 20:5070-5078. http://dx.doi.org/10.1093/emboj/20.18.5070.
19. Nonno R, Di Bari MA, Cardone F, Vaccari G, Fazzi P, Dell'Omo G, Cartoni C, Ingrosso L, Boyle A, Galeno R, Sbriccoli M, Lipp HP, Bruce M, Pocchiari M, Agrimi U. 2006. Efficient transmission and characterization of Creutzfeldt-Jakob disease strains in bank voles. PLoS Pathog 2:e12. http://dx.doi.org/10.1371/journal.ppat.0020012.
20. Neuendorf E, Weber A, Saalmueller A, Schatzl HM, Reifenberg K, Pfaff E, Groschup MH. 2004. Glycosylation deficiency at either one of the two glycan attachment sites of cellular prion protein preserves susceptibility to bovine spongiform encephalopathy and scrapie infections. J Biol Chem 279:53306-53316. http://dx.doi.org/10.1074/jbc. M410796200.
21. DeArmond SJ, Sanchez H, Yehiely F, Qiu Y, Ninchak-Casey A, Daggett V, Camerino AP, Cayetano J, Rogers M, Groth D, Torchia M, Tremblay P, Scott MR, Cohen FE, Prusiner SB. 1997. Selective neuronal targeting in prion disease. Neuron 19:1337-1348. http://dx.doi.org/10.1016/S0896-6273(00)80424-9.
22. Cancellotti E, Wiseman F, Tuzi NL, Baybutt H, Monaghan P, Aitchison L, Simpson J, Manson JC. 2005. Altered glycosylated PrP proteins can have different neuronal trafficking in brain but do not acquire scrapie-like properties. J Biol Chem 280:42909-42918. http://dx.doi.org/10.1074/jbc. M509557200.
23. Tuzi NL, Cancellotti E, Baybutt H, Blackford L, Bradford B, Plinston C, Coghill A, Hart P, Piccardo P, Barron RM, Manson JC. 2008. Host PrP glycosylation: a major factor determining the outcome of prion infection. PLoS Biol 6:e100. http://dx.doi.org/10.1371/journal.pbio.0060100.
24. Aguzzi A, Heikenwalder M, Polymenidou M. 2007. Insights into prion strains and neurotoxicity. Nat Rev Mol Cell Biol 8:552-561. http://dx.doi.org/10.1038/nrm2204.
25. Bruce ME. 2003. TSE strain variation. Br Med Bull 66:99-108. http://dx.doi.org/10.1093/bmb/66.1.99.
26. Morales R, Abid K, Soto C. 2007. The prion strain phenomenon: molecular basis and unprecedented features. Biochim Biophys Acta 1772: 681-691. http://dx.doi.org/10.1016/j.bbadis.2006.12.006.
27. Bessen RA, Marsh RF. 1994. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68:7859-7868.
28. Collinge J, Clarke AR. 2007. A general model of prion strains and their pathogenicity. Science 318:930-936. http://dx.doi.org/10.1126/science.1138718.
29. Peretz D, Williamson RA, Legname G, Matsunaga Y, Vergara J, Burton DR, DeArmond SJ, Prusiner SB, Scott MR. 2002. A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron 34:921-932. http://dx.doi.org/10.1016/S0896-6273(02)00726-2.
30. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. 1996. Molecular analysis of prion strain variation and the aetiology of "new variant" CJD. Nature 383:685-690. http://dx.doi.org/10.1038/383685a0.
31. Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, Farlow M, Dickson DW, Sima AA, Trojanowski JQ, Petersen RB, Gambetti P. 1996. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 39:767-778. http://dx.doi.org/10.1002/ana.410390613.
32. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H. 1999. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224-233.
33. Bosques CJ, Imperiali B. 2003. The interplay of glycosylation and disulfide formation influences fibrillization in a prion protein fragment. Proc Natl Acad Sci USA 100:7593-7598. http://dx.doi.org/10.1073/pnas.1232504100.
34. Zuegg J, Gready JE. 2000. Molecular dynamics simulation of human prion protein including both N-linked oligosaccharides and the GPI anchor. Glycobiology 10:959-974. http://dx.doi.org/10.1093/glycob/10.10.959.
35. Priola SA, Lawson VA. 2001. Glycosylation influences cross-species formation of protease-resistant prion protein. EMBO J 20:6692-6699. http://dx.doi.org/10.1093/emboj/20.23.6692.
36. Khalili-Shirazi A, Quaratino S, Londei M, Summers L, Tayebi M, Clarke AR, Hawke SH, Jackson GS, Collinge J. 2005. Protein conformation significantly influences immune responses to prion protein. J Immunol 174:3256-3263. http://dx.doi.org/10.4049/jimmunol.174.6.3256.
37. Nishina KA, Deleault NR, Mahal SP, Baskakov I, Luhrs T, Riek R, Supattapone S. 2006. The stoichiometry of host PrPC glycoforms modulates the efficiency of PrPSc formation in vitro. Biochemistry 45:14129-14139. http://dx.doi.org/10.1021/bi061526k.
38. Raymond GJ, Hope J, Kocisko DA, Priola SA, Raymond LD, Bossers A, Ironside J, Will RG, Chen SG, Petersen RB, Gambetti P, Rubenstein R, Smits MA, Lansbury PT, Jr, Caughey B. 1997. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature 388: 285-288. http://dx.doi.org/10.1038/40876.
39. Kimberlin RH, Walker CA. 1978. Evidence that the transmission of one source of scrapie agent to hamsters involves separation of agent strains from a mixture. J Gen Virol 39:487-496. http://dx.doi.org/10.1099/0022-1317-39-3-487.
40. Korth C, Kaneko K, Groth D, Heye N, Telling G, Mastrianni J, Parchi P, Gambetti P, Will R, Ironside J, Heinrich C, Tremblay P, DeArmond SJ, Prusiner SB. 2003. Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. Proc Natl Acad Sci USA 100:4784-4789. http://dx.doi.org/10.1073/pnas.2627989100.
41. Dickinson AG, Meikle VMH, Fraser H. 1968. Identification of a gene which controls the incubation period of some strains of scrapie agent in mice. J Comp Pathol 78:293-299. http://dx.doi.org/10.1016/0021-9975(68)90005-4.
42. Fraser H, Dickinson AG. 1968. The sequential development of the brain lesion of scrapie in three strains of mice. J Comp Pathol 78:301-311. http://dx.doi.org/10.1016/0021-9975(68)90006-6.
43. Wadsworth JD, Asante EA, Desbruslais M, Linehan JM, Joiner S, Gowland I, Welch J, Stone L, Lloyd SE, Hill AF, Brandner S, Collinge J. 2004. Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 306:1793-1796. http://dx.doi.org/10.1126/science.1103932.
44. Zanusso G, Liu D, Ferrari S, Hegyi I, Yin X, Aguzzi A, Hornemann S, Liemann S, Glockshuber R, Manson JC, Brown P, Petersen RB, Gambetti P, Sy MS. 1998. Prion protein expression in different species: analysis with a panel of new mAbs. Proc Natl Acad Sci USA 95:8812-8816. http://dx.doi.org/10.1073/pnas.95.15.8812.
45. McCutcheon S, Langeveld JP, Tan BC, Gill AC, de Wolf C, Martin S, Gonzalez L, Alibhai J, Blanco AR, Campbell L, Hunter N, Houston EF. 2014. Prion protein-specific antibodies that detect multiple TSE agents with high sensitivity. PLoS One 9:e91143. http://dx.doi.org/10.1371/journal.pone.0091143.
46. Li R, Liu T, Wong BS, Pan T, Morillas M, Swietnicki W, O'Rourke K, Gambetti P, Surewicz WK, Sy MS. 2000. Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus. J Mol Biol 301:567-573. http://dx.doi.org/10.1006/jmbi.2000.3986.
47. Race R, Meade-White K, Raines A, Raymond GJ, Caughey B, Chesebro B. 2002. Subclinical scrapie infection in a resistant species: persistence, replication, and adaptation of infectivity during four passages. J Infect Dis 186(Suppl 2):S166-170. http://dx.doi.org/10.1086/344267.
48. Manson JC, Clarke AR, McBride PA, McConnell I, Hope J. 1994. PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration 3:331-340.
49. Bueler H, Raeber A, Sailer A, Fischer M, Aguzzi A, Weissmann C. 1994. High prion and PrPSc levels but delayed onset of disease in scrapieinoculated mice heterozygous for a disrupted PrP gene. Mol Med 1:19-30.
50. Manson J. 1996. Prnp gene dosage, allelic specificity and gene regulation in the transmissible spongiform encephalopathies, p 239-245. In Court L, Dodet B (ed), Transmissible subacute spongiform encephalopathies: prion diseases. Elsevier, Paris, France.
51. Bishop MT, Will RG, Manson JC. 2010. Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci USA 107:12005-12010. http://dx.doi.org/10.1073/pnas.1004688107.
52. Cancellotti E, Bradford BM, Tuzi NL, Hickey RD, Brown D, Brown KL, Barron RM, Kisielewski D, Piccardo P, Manson JC. 2010. Glycosylation of PrPCdetermines timing of neuroinvasion and targeting in the brain following transmissible spongiform encephalopathy infection by a peripheral route. J Virol 84:3464-3475. http://dx.doi.org/10.1128/JVI.02374-09.
53. Lewis V, Hill AF, Haigh CL, Klug GM, Masters CL, Lawson VA, Collins SJ. 2009. Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infection. J Neuropathol Exp Neurol 68: 1125-1135. http://dx.doi.org/10.1097/NEN.0b013e3181b96981.
54. Ikeda S, Kobayashi A, Kitamoto T. 2008. Thr but Asn of the N-glycosylation sites of PrP is indispensable for its misfolding. Biochem Biophys Res Commun 369:1195-1198. http://dx.doi.org/10.1016/j.bbrc.2008.03.014.
55. Somerville RA, Hamilton S, Fernie K. 2005. Transmissible spongiform encephalopathy strain, PrP genotype and brain region all affect the degree of glycosylation of PrPSc. J Gen Virol 86:241-246. http://dx.doi.org/10.1099/vir.0.80251-0.
56. Beringue V, Mallinson G, Kaisar M, Tayebi M, Sattar Z, Jackson G, Anstee D, Collinge J, Hawke S. 2003. Regional heterogeneity of cellular prion protein isoforms in the mouse brain. Brain 126:2065-2073. http://dx.doi.org/10.1093/brain/awg205.
57. Sigurdson CJ, Nilsson KP, Hornemann S, Manco G, Fernandez-Borges N, Schwarz P, Castilla J, Wuthrich K, Aguzzi A. 2010. A molecular switch controls interspecies prion disease transmission in mice. J Clin Investig 120:2590-2599. http://dx.doi.org/10.1172/JCI42051.
58. Telling GC, Scott M, Mastrianni J, Gabizon R, Torchia M, Cohen FE, DeArmond SJ, Prusiner SB. 1995. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83:79-90. http://dx.doi.org/10.1016/0092-8674(95)90236-8.
59. Deleault NR, Lucassen RW, Supattapone S. 2003. RNA molecules stimulate prion protein conversion. Nature 425:717-720. http://dx.doi.org/10.1038/nature01979.
60. Graham JF, Agarwal S, Kurian D, Kirby L, Pinheiro TJ, Gill AC. 2010. Low density subcellular fractions enhance disease-specific prion protein misfolding. J Biol Chem 285:9868-9880. http://dx.doi.org/10.1074/jbc. M109.093484.